跳至主要内容
临床试验/NCT07480109
NCT07480109招募中不适用

The 'Power of Pork Protein' (From Diverse Pork Products) to Promote Health and Well-being During GLP-1 Medication Use in Middle-aged Women (With Overweight/Obesity)

University of Texas at Austin2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2026年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
75
试验地点
2
主要终点
Body Composition

研究概览

简要总结

Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.

详细描述

Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week, parallel-design, dietary protein intervention trial. The participants will be randomized into the following groups: GLP-1 ONLY (no dietary intervention) or GLP-1 + Protein. The GLP-1 only group will take/continue to take the respective GLP-1 medication as prescribed by their physician, whereas the GLP-1 + Protein group will take/continue to take the respective GLP-1 medication as prescribed by their physician but will be provided with a variety of protein-rich pork foods to yield 20 g of protein, twice daily, for 12 weeks, totaling ~40 g high quality protein. In addition, recipes will be provided to support the consumption of the protein-rich foods within the breakfast meal (required) and in other eating occasions. Baseline and post-study assessments include body composition, eating behavior, food intake, appetite, satiety, food cravings, food reward, and health & well-being.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult women (30-60 years)
  • Having overweight or obesity (BMI >25 kg/m2)
  • Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician
  • Willing and able to maintain current inactivity patterns throughout the study
  • Willing and able to follow all study procedures
  • Generally healthy, as assessed from the medical history questionnaire

排除标准

  • Adults (<30 years or >60 years)
  • Having normal weight (BMI <25 kg/m2)
  • Not prescribed GLP-1 medication by a physician
  • Those on GLP-1 medication longer than 4 weeks (during time of screening)
  • Currently on a high-protein or other specific diet
  • Unwilling and/or unable to maintain current inactivity patterns throughout the study
  • Unwilling and/or unable to follow all study procedures
  • Unwilling and/or unable to eat pork (for the GLP-1 + Protein group)
  • Not generally healthy, as assessed from the medical history questionnaire

研究组 & 干预措施

GLP-1 Only (no dietary intervention)

No Intervention

The participants in the GLP-1 only group will take/continue to take the respective GLP-1 medication as prescribed by their physician. They will not receive a dietary intervention.

GLP-1 + Protein

Experimental

The participants in the GLP-1 + Protein group will take/continue to take the respective GLP-1 medication as prescribed by their physician but will be provided with a variety of protein-rich pork foods to yield 20 g of protein, twice daily, for 12 weeks, totaling ~40 g high quality protein. In addition, recipes will be provided to support the consumption of the protein-rich foods within the breakfast meal (required) and in other eating occasions.

干预措施: Protein Rich Foods (Behavioral)

结局指标

主要结局

Body Composition

时间窗: Baseline and 12 weeks

Whole body total, fat, and fat free mass will be determined with Dual X-ray Absorptiometry (DXA). The DXA uses a linear X-ray fan beam with switched-pulse dual-energy and a multi-element detector array. The whole body scan takes \<1.8 sec with radiation exposure of 0.01mGy.

Muscle Mass

时间窗: Baseline and 12 weeks

D3-creatine method determines muscle mass by measuring the total-body creatine pool size through isotope dilution. Participants will ingest 30 mg of D3-creatine powder dissolved in water. Following consumption, three spot urine samples will be collected at 24-, 48-, and 72-hours using study supplies.

3-day Average Daily Intake

时间窗: Baseline and 12 weeks

Free-living energy intake, portion sizes, and eating patterns will be assessed using 3 24-h dietary recalls will be collected via a phone intervention or using the computerized ASA24 (Automated Self-administered 24-hour Dietary Assessment Tool) program. The participants will recall everything consumed (beverages and foods) over the previous day.

次要结局

  • Energy Expenditure and Sleep(Baseline and 12 weeks)
  • Food Noise(Baseline, 2 week, 4 week, 6 week, 8 week, 10 week, 12 weeks)
  • Depression(Baseline and 12 weeks)
  • Anxiety(Baseline and 12 weeks)
  • Pork Consumption(Baseline and 12 weeks)
  • Appetite, Satiety, Food Craving and Mood(Baseline and 12 weeks)
  • Control of Eating(Baseline and 12 weeks)
  • Health and Well-being Questionnaire(Baseline and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heather Leidy

Professor

University of Texas at Austin

研究点 (2)

Loading locations...

相似试验